https://www.oncologynurseadvisor.com Tue, 12 Feb 2019 04:15:29 +0000 en-US hourly 1 https://wordpress.org/?v=6.4.3 https://www.oncologynurseadvisor.com/wp-content/uploads/sites/13/2024/01/cropped-CTA-ONA-HEM-favicon-32x32.png https://www.oncologynurseadvisor.com 32 32 https://www.oncologynurseadvisor.com/home/cancer-types/head-and-neck-cancer/no-intervention-for-small-thyroid-cancers-may-cause-anxiety/ Fri, 17 Mar 2017 19:30:00 +0000 https://www.oncologynurseadvisor.com/uncategorized/no-intervention-for-small-thyroid-cancers-may-cause-anxiety/ Deciding not to intervene for small, incidentally identified thyroid cancer may cause patients to experience anxiety and feelings of isolation.]]> https://www.oncologynurseadvisor.com/home/hot-topics/side-effect-management/regorafenib-improves-quality-adjusted-survival-in-sarcoma/ Fri, 17 Mar 2017 19:00:00 +0000 https://www.oncologynurseadvisor.com/uncategorized/regorafenib-improves-quality-adjusted-survival-in-sarcoma/ In patients with soft tissue sarcoma pretreated with doxorubicin, treatment with regorafenib significantly reduced the risk of progression symptoms or toxicity.]]> https://www.oncologynurseadvisor.com/home/headlines/conference-coverage/sgo-2017-annual-meeting/screening-increases-early-palliative-care-reduces-aggressive-eol-measures/ Thu, 16 Mar 2017 18:00:00 +0000 https://www.oncologynurseadvisor.com/uncategorized/screening-increases-early-palliative-care-reduces-aggressive-eol-measures/ Universal screening of women with gynecologic malignancies for early palliative care decreased the use of aggressive measures at the end of life.]]> https://www.oncologynurseadvisor.com/home/headlines/conference-coverage/sgo-2017-annual-meeting/high-rates-of-persistent-opioid-use-6-months-after-rt-for-cervical-cancer/ Tue, 14 Mar 2017 15:00:00 +0000 https://www.oncologynurseadvisor.com/uncategorized/high-rates-of-persistent-opioid-use-6-months-after-rt-for-cervical-cancer/ Nearly 3 in 10 cervical cancer survivors were still using opioids at 6 months after completing radiotherapy.]]> https://www.oncologynurseadvisor.com/home/headlines/conference-coverage/sgo-2017-annual-meeting/hpv-vaccination-discussions-need-to-focus-on-education-awareness/ Mon, 13 Mar 2017 19:00:00 +0000 https://www.oncologynurseadvisor.com/uncategorized/hpv-vaccination-discussions-need-to-focus-on-education-awareness/ The top reasons for not initiating HPV vaccination are necessity, safety, and knowledge, rather than a lack of discussions on sexuality.]]> https://www.oncologynurseadvisor.com/home/headlines/conference-coverage/sgo-2017-annual-meeting/ovarian-cancer-distinct-clusters-of-chemotherapy-nonresponders-identified/ Mon, 13 Mar 2017 18:00:00 +0000 https://www.oncologynurseadvisor.com/uncategorized/ovarian-cancer-distinct-clusters-of-chemotherapy-nonresponders-identified/ A study that integrated genomic and clinical data identified 3 distinct clusters of patients with serous epithelial ovarian cancer who do not respond to chemotherapy.]]> https://www.oncologynurseadvisor.com/home/headlines/conference-coverage/sgo-2017-annual-meeting/recovery-program-after-laparotomy-more-cost-effective-than-usual-care/ Mon, 13 Mar 2017 16:00:00 +0000 https://www.oncologynurseadvisor.com/uncategorized/recovery-program-after-laparotomy-more-cost-effective-than-usual-care/ An enhanced recovery program is more cost-effective than usual care in patients undergoing primary cytoreductive surgery for ovarian cancer.]]> https://www.oncologynurseadvisor.com/home/headlines/conference-coverage/sgo-2017-annual-meeting/rucaparib-active-in-relapsed-platinum-sensitive-ovarian-cancer/ Mon, 13 Mar 2017 15:30:00 +0000 https://www.oncologynurseadvisor.com/uncategorized/rucaparib-active-in-relapsed-platinum-sensitive-ovarian-cancer/ Rucaparib was active with an acceptable safety profile in patients with relapsed, platinum-sensitive high-grade ovarian carcinoma with germline or somatic BRCA mutations.]]> https://www.oncologynurseadvisor.com/home/headlines/conference-coverage/sgo-2017-annual-meeting/completing-hpv-vaccine-doses-has-no-added-protective-benefit/ Mon, 13 Mar 2017 14:00:00 +0000 https://www.oncologynurseadvisor.com/uncategorized/completing-hpv-vaccine-doses-has-no-added-protective-benefit/ There was no additional protective effect with a third dose of the human papillomavirus vaccine compared with receiving only 2 doses of the vaccine.]]> https://www.oncologynurseadvisor.com/home/cancer-types/lung-cancer/proportion-of-never-smokers-with-nsclc-is-on-the-rise/ Fri, 10 Mar 2017 21:00:00 +0000 https://www.oncologynurseadvisor.com/uncategorized/proportion-of-never-smokers-with-nsclc-is-on-the-rise/ A study of a large, diverse patient population appears to show an increasing incidence of lung cancer in patients who have never smoked tobacco.]]>